These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25820321)

  • 1. Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.
    Sandén E; Dyberg C; Krona C; Visse E; Carén H; Northcott PA; Kool M; Ståhl N; Persson A; Englund E; Johnsen JI; Siesjö P; Darabi A
    J Neurooncol; 2015 May; 123(1):1-13. PubMed ID: 25820321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas.
    Teo WY; Elghetany MT; Shen J; Man TK; Li X; Chintagumpala M; Su JM; Dauser R; Whitehead W; Adesina AM; Lau CC
    J Neurooncol; 2014 Nov; 120(2):293-301. PubMed ID: 25115738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation.
    Sandén E; Dyberg C; Krona C; Gallo-Oller G; Olsen TK; Enríquez Pérez J; Wickström M; Estekizadeh A; Kool M; Visse E; Ekström TJ; Siesjö P; Johnsen JI; Darabi A
    Sci Rep; 2017 Apr; 7():46366. PubMed ID: 28417956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas.
    Bharambe HS; Paul R; Panwalkar P; Jalali R; Sridhar E; Gupta T; Moiyadi A; Shetty P; Kazi S; Deogharkar A; Masurkar S; Yogi K; Kunder R; Gadewal N; Goel A; Goel N; Chinnaswamy G; Ramaswamy V; Shirsat NV
    Acta Neuropathol Commun; 2019 Apr; 7(1):52. PubMed ID: 30944042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells.
    da Silva PBG; Teixeira Dos Santos MC; Rodini CO; Kaid C; Pereira MCL; Furukawa G; da Cruz DSG; Goldfeder MB; Rocha CRR; Rosenberg C; Okamoto OK
    Oncotarget; 2017 Mar; 8(12):19192-19204. PubMed ID: 28186969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients.
    Priller M; Pöschl J; Abrão L; von Bueren AO; Cho YJ; Rutkowski S; Kretzschmar HA; Schüller U
    Clin Cancer Res; 2011 Nov; 17(21):6791-801. PubMed ID: 21918172
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Tao R; Murad N; Xu Z; Zhang P; Okonechnikov K; Kool M; Rivero-Hinojosa S; Lazarski C; Zheng P; Liu Y; Eberhart CG; Rood BR; Packer R; Pei Y
    Cancer Res; 2019 Apr; 79(8):1967-1980. PubMed ID: 30862721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice.
    Jenkins NC; Rao G; Eberhart CG; Pedone CA; Dubuc AM; Fults DW
    J Neurooncol; 2016 Feb; 126(3):415-24. PubMed ID: 26518543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
    Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
    Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.
    Smits M; van Rijn S; Hulleman E; Biesmans D; van Vuurden DG; Kool M; Haberler C; Aronica E; Vandertop WP; Noske DP; Würdinger T
    Clin Cancer Res; 2012 Aug; 18(15):4048-58. PubMed ID: 22696229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
    Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
    J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.
    Ellison DW; Onilude OE; Lindsey JC; Lusher ME; Weston CL; Taylor RE; Pearson AD; Clifford SC;
    J Clin Oncol; 2005 Nov; 23(31):7951-7. PubMed ID: 16258095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas.
    Son EI; Kim IM; Kim DW; Yim MB; Kang YN; Lee SS; Kwon KY; Suh SI; Kwon TK; Lee JJ; Kim DS; Kim SP
    Pathol Int; 2003 Feb; 53(2):67-73. PubMed ID: 12588433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.
    Korshunov A; Remke M; Werft W; Benner A; Ryzhova M; Witt H; Sturm D; Wittmann A; Schöttler A; Felsberg J; Reifenberger G; Rutkowski S; Scheurlen W; Kulozik AE; von Deimling A; Lichter P; Pfister SM
    J Clin Oncol; 2010 Jun; 28(18):3054-60. PubMed ID: 20479417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
    Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
    Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular fingerprint for medulloblastoma.
    Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
    Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
    Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rethinking medulloblastoma from a targeted therapeutics perspective.
    Hashimoto Y; Penas-Prado M; Zhou S; Wei J; Khatua S; Hodges TR; Sanai N; Xiu J; Gatalica Z; Kim L; Kesari S; Rao G; Spetzler D; Heimberger A
    J Neurooncol; 2018 Sep; 139(3):713-720. PubMed ID: 29869738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma.
    Burger MC; Brucker DP; Baumgarten P; Ronellenfitsch MW; Wanka C; Hasselblatt M; Eccles MR; Klingebiel T; Weller M; Rieger J; Mittelbronn M; Steinbach JP
    Int J Oncol; 2012 Jul; 41(1):235-41. PubMed ID: 22552444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.